Department of Medicine, National Yang-Ming University Hospital, I-Lan, Taiwan, ROC; Division of Allergy, Immunology, Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; Department of Medicine, Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
J Chin Med Assoc. 2014 Feb;77(2):75-82. doi: 10.1016/j.jcma.2013.11.001. Epub 2013 Dec 15.
Lung involvement is one of the major systemic manifestations of primary Sjögren's syndrome (pSS). This study aims to demonstrate the correlation between high-resolution computed tomography (HRCT), pulmonary function test (PFT) results, and outcome in these patients.
Forty-four pSS patients were enrolled and their PFT results and HRCT findings/scores were retrospectively investigated.
All patients had reduced carbon monoxide-diffusing capacity (DLCO; <75% of the predicted value); <60% of the predicted value of peak expiratory flow (PEF), of forced vital capacity (FVC), and of forced expiratory volume in the 1st second (FEV1) were noted in 15 (34.1%) patients, 13 (29.5%) patients, and 12 (27.3%) patients, respectively. HRCT scores had a negative correlation with DLCO (r = -0.376, p = 0.012), but not with other PFT results. Twelve patients (27.3%) expired during a mean follow-up of 3.7 years; 11 (91.7%) patients died of respiratory failure in the lung-involved patients, of which three were present with pneumonia. The expired patients had lower predicted values of FEV1 (63.1 ± 19.4% vs. 79.0 ± 22.7%, p = 0.017), FVC (58.7 ± 20.4% vs. 77.1 ± 17.5%, p = 0.005), and PEF (54.3 ± 20.5% vs. 72.0 ± 24.8%, p = 0.035), and higher HRCT scores (9.2 ± 5.7 vs. 5.2 ± 3.5, p = 0.033) than those patients who survived. Patients with FEV1, FVC, PEF < 60% of the predicted value, or high HRCT score (13-18) presented shorter median overall survival (p = 0.005, p < 0.001, p = 0.021, p < 0.001, respectively). Multivariate analysis adjusted for PFT results showed that HRCT ≥13 was an independent risk factor for mortality (p = 0.007).
The clinical outcome of pSS patients with lung involvement in Taiwan is not very favorable. Although HRCT score was poorly correlated with PFT, high HRCT score was significantly associated with higher mortality.
肺部受累是原发性干燥综合征(pSS)的主要系统表现之一。本研究旨在证明高分辨率计算机断层扫描(HRCT)、肺功能测试(PFT)结果与这些患者的预后之间的相关性。
共纳入 44 例 pSS 患者,回顾性调查其 PFT 结果和 HRCT 检查/评分。
所有患者均存在一氧化碳弥散量降低(DLCO;<75%预计值);15 例(34.1%)、13 例(29.5%)和 12 例(27.3%)患者的峰流速(PEF)、用力肺活量(FVC)和第一秒用力呼气量(FEV1)低于预计值的 60%。HRCT 评分与 DLCO 呈负相关(r = -0.376,p = 0.012),但与其他 PFT 结果无关。12 例(27.3%)患者在平均 3.7 年的随访期间死亡;11 例(91.7%)肺部受累患者因呼吸衰竭死亡,其中 3 例为肺炎。死亡患者的 FEV1(63.1±19.4%对 79.0±22.7%,p = 0.017)、FVC(58.7±20.4%对 77.1±17.5%,p = 0.005)和 PEF(54.3±20.5%对 72.0±24.8%,p = 0.035)预计值更低,HRCT 评分(9.2±5.7 对 5.2±3.5,p = 0.033)更高。FEV1、FVC、PEF 预测值<60%或 HRCT 评分较高(13-18)的患者中位总生存期更短(p = 0.005、p<0.001、p = 0.021、p<0.001)。多变量分析校正 PFT 结果后,HRCT≥13 是死亡的独立危险因素(p = 0.007)。
台湾 pSS 肺部受累患者的临床预后并不十分理想。虽然 HRCT 评分与 PFT 相关性较差,但高 HRCT 评分与死亡率显著相关。